Philadelphia Pharmaceuticals Company (ASE:PHIL)
1.720
-0.010 (-0.58%)
At close: May 21, 2026
ASE:PHIL Balance Sheet
Financials in millions JOD. Fiscal year is January - December.
Millions JOD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 1.77 | 1.83 | 1.65 | 1.4 | 1.5 | 1.66 |
Cash & Short-Term Investments | 1.77 | 1.83 | 1.65 | 1.4 | 1.5 | 1.66 |
Cash Growth | -0.58% | 10.53% | 18.11% | -6.64% | -9.82% | 3.74% |
Accounts Receivable | 6.76 | 6.53 | 6.38 | 6.45 | 6.24 | 6.7 |
Other Receivables | 0.05 | 0.04 | 0.05 | - | 0.07 | 0.07 |
Receivables | 6.8 | 6.56 | 6.43 | 6.45 | 6.31 | 6.78 |
Inventory | 2.51 | 2.27 | 1.9 | 1.89 | 1.42 | 1.66 |
Prepaid Expenses | 0.42 | 0.36 | 0.16 | 0.18 | 0.14 | 0.11 |
Other Current Assets | 0.13 | 0.12 | 0.1 | 0.19 | 0.03 | 0.03 |
Total Current Assets | 11.63 | 11.13 | 10.24 | 10.12 | 9.39 | 10.24 |
Property, Plant & Equipment | 2.81 | 2.83 | 2.88 | 2.06 | 2.29 | 2.39 |
Other Intangible Assets | - | - | - | - | - | 2.44 |
Long-Term Deferred Charges | 3.18 | 3.26 | 3.55 | 3.85 | 4.14 | - |
Total Assets | 17.63 | 17.22 | 16.67 | 16.03 | 15.82 | 15.07 |
Accounts Payable | 1.26 | 1.33 | 1.23 | 1.35 | 1.13 | 1.09 |
Accrued Expenses | 0.23 | 0.28 | 0.24 | 0.24 | 0.28 | 0.22 |
Short-Term Debt | 0.89 | 0.51 | 0.67 | 1.49 | 1.83 | 1.45 |
Current Portion of Long-Term Debt | 0.72 | 0.54 | 0.48 | - | - | - |
Current Income Taxes Payable | 0.2 | 0.27 | 0.14 | 0.13 | 0.1 | 0.08 |
Other Current Liabilities | 0.37 | 0.06 | 0.04 | 0.06 | 0.09 | 0.11 |
Total Current Liabilities | 3.67 | 2.99 | 2.79 | 3.28 | 3.44 | 2.94 |
Long-Term Debt | 0.71 | 0.71 | 0.84 | - | - | - |
Total Liabilities | 4.38 | 3.7 | 3.63 | 3.28 | 3.44 | 2.94 |
Common Stock | 7.5 | 7.5 | 7.5 | 7.5 | 7.5 | 7.5 |
Retained Earnings | 5.75 | 6.02 | 5.54 | 5.24 | 4.89 | 4.63 |
Shareholders' Equity | 13.25 | 13.52 | 13.04 | 12.74 | 12.39 | 12.13 |
Total Liabilities & Equity | 17.63 | 17.22 | 16.67 | 16.03 | 15.82 | 15.07 |
Total Debt | 2.31 | 1.76 | 1.99 | 1.49 | 1.83 | 1.45 |
Net Cash (Debt) | -0.54 | 0.07 | -0.33 | -0.09 | -0.33 | 0.21 |
Net Cash Per Share | -0.07 | 0.01 | -0.04 | -0.01 | -0.04 | 0.03 |
Filing Date Shares Outstanding | 7.5 | 7.5 | 7.5 | 7.5 | 7.5 | 7.5 |
Total Common Shares Outstanding | 7.5 | 7.5 | 7.5 | 7.5 | 7.5 | 7.5 |
Working Capital | 7.96 | 8.14 | 7.45 | 6.83 | 5.96 | 7.3 |
Book Value Per Share | 1.77 | 1.80 | 1.74 | 1.70 | 1.65 | 1.62 |
Tangible Book Value | 13.25 | 13.52 | 13.04 | 12.74 | 12.39 | 9.69 |
Tangible Book Value Per Share | 1.77 | 1.80 | 1.74 | 1.70 | 1.65 | 1.29 |
Land | 1.05 | 1.05 | 1.05 | 0.12 | 0.12 | 0.12 |
Buildings | 1.65 | 1.65 | 1.64 | 1.6 | 1.59 | 1.59 |
Machinery | 3.86 | 3.83 | 3.82 | 3.73 | 3.67 | 3.58 |